SRXH is trading 5.4% down now at $0.11, extending a sharp multi-day slide following its EMJ Crypto Technologies acquisition and rebranding to SRX Global Inc.
- The stock remains under pressure on June 23, 2026, even after the company announced a strategic investment in clinical-stage biodefense firm ARMR Sciences.
- The ongoing decline suggests that investors remain cautious regarding the company's recent business transformation and capital allocation moves.